Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
871 participants
OBSERVATIONAL
2023-03-01
2024-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI-Enhanced Optimization of Acute Levodopa Challenge Test
NCT06949865
A Pilot Study to Evaluate the Severity of Motor Dysfunction in Parkinson's Disease Based on AI Video Analysis
NCT03655171
Application of Machine Learning Method in Validation of Screening Cognitive Test for Parkinsonisms
NCT04858893
Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
NCT07244640
Automated Parkinson's Disease (PD) Motor Symptom Assessment for Deep Brain Stimulation (DBS) Programming
NCT01429220
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
video recording
Patients' performance of MDS-UPDRS III will be recorded.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 20 to 80 years old
* Good compliance, voluntarily joining the study, and able to sign an informed consent form or have it signed by a legal representative
Exclusion Criteria
* Unable to sign written informed consent or unable to complete the trial due to other reasons
* Other situations in which the researcher deems the participant unsuitable for this study
* Participation in other clinical trials
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Affiliated Hospital of Soochow University
OTHER
Beijing Hospital
OTHER_GOV
Beijing Tiantan Hospital
OTHER
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
OTHER
Fujian Medical University Union Hospital
OTHER
Guangdong Provincial People's Hospital
OTHER
West China Hospital
OTHER
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University
Beijing, Beijing Municipality, China
Beijing Hospital, Neurology Department
Beijing, Beijing Municipality, China
Department of Neurology, Fujian Medical University Union Hospital
Fuzhou, Fujian, China
Department of Neurology, Guangdong Neuroscience Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences
Guangzhou, Guangdong, China
Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China
Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
Department of Neurology and Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Department of Neurology, West China Hospital, Sichuan University
Chengdu, Sichuan, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
u3
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.